Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | BMS-986484 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on BMS-986484 (Aug 2024). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| BMS-986484 | BMS986484|BMS 986484 | Limited information is currently available on BMS-986484 (Aug 2024). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06544655 | Phase I | BMS-986484 + Nivolumab BMS-986484 BMS-986484 + Capecitabine + Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin | A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors | Recruiting | USA | CAN | AUS | 1 |